Lonza Consumer Health and Nutrition Joins Clean Label Alliance

November 07, 2018

Greenwood, SC (USA), 6 November 2018 – Lonza today announced that its Consumer Health & Nutrition (CHN) team will be a founding member of the Clean Label Alliance, a new initiative to help manufacturers develop or transition to clean labels to meet evolving consumer preferences. Bringing together five leading dietary supplement innovators and coordinated by RIBUS Inc., the Clean Label Alliance will provide manufacturers with support and problem-solving solutions. It will be launched officially at this year’s SupplySide West Expo in Las Vegas, NV (USA) from 8-9 November 2018.

Developed in response to the increasing demand by consumers for greater transparency, and cleaner and simpler dietary supplements, the Clean Label Alliance will offer expert guidance to companies bringing nutritional supplements to consumers. As supplement manufacturers transition to cleaner labels, they must overcome both formulation and production challenges. The Clean Label Alliance will offer premium resources and technical solutions to help manufacturers to produce clean-label supplements more easily and efficiently.

Beth Tormey, Sr. Vice President, Head of Global Business Unit, Lonza Consumer Health & Nutrition, commented: “Approximately 80 percent of consumers now want to know what is in the products they use. Manufacturers know how to make supplements in the traditional way, but they may not have the experience in-house to make the transition to clean-label products to meet this growing demand. The Clean Label Alliance bridges this gap and applies years of combined member expertise in clean-label ingredients, formulations, dosage forms and manufacturing to help supplement makers get more desirable products to market faster.”

More information is available at www.CleanLabelAlliance.com.

About Lonza

Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. As an integrated solutions provider, Lonza is boosting its value creation along and beyond the healthcare continuum with a strong focus on patient healthcare, consumer preventive healthcare and consumer's healthy environment.

Lonza harnesses science and technology to create products that support safer and healthier living and that enhance the overall quality of life. With the recent Capsugel acquisition, Lonza now offers products and services from the custom development and manufacturing of active pharmaceutical ingredients to innovative dosage forms for the pharma and consumer health and nutrition industries.

Benefiting from its regulatory expertise, Lonza is able to transfer its know-how from pharma to hygiene and fast-moving consumer goods all the way to coatings and composites and the preservation and protection of agricultural goods and other natural resources.

Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 100 sites and offices and approximately 14,500 full-time employees worldwide. The company generated sales of CHF 5.1 billion in 2017 with a CORE EBITDA of CHF 1.3 billion. Further information can be found at www.lonza.com.  

Lonza Contact Details

Dirk Oehlers, Head Investor Relations
Lonza Group Ltd
Tel +41 61 316 8540

Constance Ward, Head External Communications
Lonza Group Ltd
Tel +41 61 316 8840